NEW YORK (GenomeWeb News) – Evogene today reported that its third-quarter revenues increased nearly three-fold year over year, and it swung to a profit from a loss.

The Rehovot, Israel-based firm reported total revenues of $2.6 million for the three-month period ended Sept. 30, 2009, compared to $870,000 for the third quarter of 2008.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.